Put Options

27 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.61 - $23.34 $34,342 - $51,348
2,200 Added 16.54%
15,500 $242,000
Q2 2024

Aug 14, 2024

SELL
$11.83 - $24.05 $165,620 - $336,700
-14,000 Reduced 51.28%
13,300 $227,000
Q1 2024

May 15, 2024

BUY
$12.42 - $17.29 $198,720 - $276,640
16,000 Added 141.59%
27,300 $426,000
Q4 2023

Feb 14, 2024

SELL
$11.13 - $15.78 $31,164 - $44,184
-2,800 Reduced 19.86%
11,300 $168,000
Q3 2023

Nov 15, 2023

SELL
$16.15 - $42.35 $163,115 - $427,735
-10,100 Reduced 41.74%
14,100 $227,000
Q2 2023

Aug 23, 2023

BUY
$40.29 - $82.51 $519,741 - $1.06 Million
12,900 Added 114.16%
24,200 $1 Million
Q1 2023

May 15, 2023

SELL
$56.44 - $118.81 $1.27 Million - $2.67 Million
-22,500 Reduced 66.57%
11,300 $658,000
Q4 2022

Feb 14, 2023

BUY
$63.98 - $85.37 $550,228 - $734,182
8,600 Added 34.13%
33,800 $2.48 Million
Q3 2022

Nov 14, 2022

BUY
$67.99 - $89.57 $217,567 - $286,624
3,200 Added 14.55%
25,200 $1.94 Million
Q2 2022

Aug 15, 2022

SELL
$56.6 - $89.9 $283,000 - $449,500
-5,000 Reduced 18.52%
22,000 $1.59 Million
Q1 2022

May 16, 2022

SELL
$60.15 - $84.52 $396,990 - $557,832
-6,600 Reduced 19.64%
27,000 $2.27 Million
Q4 2021

Feb 14, 2022

BUY
$75.08 - $121.99 $127,636 - $207,383
1,700 Added 5.33%
33,600 $2.68 Million
Q3 2021

Nov 12, 2021

SELL
$116.17 - $194.55 $2.92 Million - $4.88 Million
-25,100 Reduced 44.04%
31,900 $3.71 Million
Q2 2021

Aug 06, 2021

BUY
$130.4 - $225.58 $5.03 Million - $8.71 Million
38,600 Added 209.78%
57,000 $12.8 Million
Q1 2021

May 14, 2021

BUY
$124.11 - $190.17 $2.28 Million - $3.5 Million
18,400 New
18,400 $2.31 Million
Q4 2020

Feb 12, 2021

SELL
$112.16 - $174.14 $7.23 Million - $11.2 Million
-64,500 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$58.05 - $111.31 $696,600 - $1.34 Million
-12,000 Reduced 15.69%
64,500 $7.03 Million
Q2 2020

Aug 13, 2020

SELL
$57.2 - $74.41 $4.55 Million - $5.92 Million
-79,500 Reduced 50.96%
76,500 $4.41 Million
Q1 2020

May 11, 2020

BUY
$57.05 - $95.75 $2.91 Million - $4.88 Million
51,000 Added 48.57%
156,000 $10.9 Million
Q4 2019

Feb 12, 2020

BUY
$68.3 - $93.8 $1.76 Million - $2.42 Million
25,800 Added 32.58%
105,000 $8.95 Million
Q3 2019

Nov 14, 2019

BUY
$61.86 - $97.8 $1.38 Million - $2.18 Million
22,300 Added 39.19%
79,200 $5.82 Million
Q2 2019

Aug 20, 2019

BUY
$42.22 - $63.23 $2.4 Million - $3.6 Million
56,900 New
56,900 $3.6 Million
Q1 2019

May 15, 2019

SELL
$31.96 - $56.12 $600,848 - $1.06 Million
-18,800 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$28.72 - $52.63 $258,480 - $473,670
-9,000 Reduced 32.37%
18,800 $617,000
Q3 2018

Nov 14, 2018

BUY
$32.0 - $52.4 $387,200 - $634,040
12,100 Added 77.07%
27,800 $1.46 Million
Q1 2018

May 15, 2018

SELL
$19.3 - $23.65 $169,840 - $208,120
-8,800 Reduced 35.92%
15,700 $342,000
Q4 2017

Feb 14, 2018

BUY
$16.3 - $21.9 $399,350 - $536,550
24,500
24,500 $495,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.23B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.